Holen Sie sich die Stockscreener-App
26.43
2.58%
-0.70
Handel nachbörslich:
26.43
Schlusskurs vom Vortag:
$27.13
Offen:
$26.76
24-Stunden-Volumen:
188.09K
Relative Volume:
0.64
Marktkapitalisierung:
$1.54B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-5.64%
1M Leistung:
-2.04%
6M Leistung:
+49.58%
1J Leistung:
+0.00%
1-Tages-Spanne:
$26.36
$27.04
1-Wochen-Bereich:
$26.36
$28.40
52-Wochen-Spanne:
$13.25
$30.00
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
Firmenname
Kestra Medical Technologies Ltd
Sektor
Telefon
(425) 279-8002
Adresse
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
Vergleichen Sie KMTS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KMTS
Kestra Medical Technologies Ltd
|
26.43 | 1.58B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
575.40 | 204.83B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
195.16 | 55.94B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.35 | 39.48B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
242.85 | 35.73B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
42.00 | 34.74B | 27.43B | 1.27B | 1.01B | 1.5829 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Eingeleitet | BTIG Research | Buy |
| 2025-03-31 | Eingeleitet | BofA Securities | Buy |
| 2025-03-31 | Eingeleitet | Goldman | Neutral |
| 2025-03-31 | Eingeleitet | Piper Sandler | Overweight |
| 2025-03-31 | Eingeleitet | Stifel | Buy |
| 2025-03-31 | Eingeleitet | Wells Fargo | Overweight |
| 2025-03-31 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Kestra Medical Technologies Ltd Aktie (KMTS) Neueste Nachrichten
Can Kestra Medical Technologies Ltd. stock maintain operating margins2025 Volume Leaders & AI Driven Stock Reports - Улправда
Will Kestra Medical Technologies Ltd. stock benefit from AI adoptionJuly 2025 Weekly Recap & Risk Controlled Swing Alerts - Улправда
Kestra Medical Technologies sees Q2 revenue between $22.2M and $22.6M - MSN
Is Kestra Medical Technologies Ltd. stock positioned for long term growth2025 Investor Takeaways & Community Shared Stock Ideas - DonanımHaber
Is Kestra Medical Technologies (KMTS) Overvalued After Its Recent Share Price Climb? - Sahm
Kestra Medical prices upsized $138M offering - MSN
Kestra Medical Technologies reports strong earnings growth - MSN
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap UpHere's What Happened - MarketBeat
Kestra Medical Technologies (KMTS) Q2: Revenue Growth, Losses Deepen, Testing Bullish Scale Narratives - Sahm
Wells Fargo Maintains Kestra Medical Technologies (KMTS) Overweight Recommendation - Nasdaq
Kestra Medical Technologies’ revenue up 53% to USD 22.6M in Q2 FY26 - Medical Buyer
Kestra Medical Technologies, Ltd. $KMTS Position Increased by Eventide Asset Management LLC - MarketBeat
Kestra Medical Technologies Reports Strong Earnings Growth - TipRanks
Wells Fargo Raises Price Target for KMTS, Maintains Overweight R - GuruFocus
Kestra Medical price target raised to $30 from $27 at Piper Sandler - MSN
Kestra Medical Technologies stock price target raised by Stifel to $30 - Investing.com Australia
Kestra Medical Technologies stock price target raised to $30 from $27 at Piper Sandler By Investing.com - Investing.com South Africa
Kestra Medical Technologies stock price target raised to $30 from $27 at Piper Sandler - Investing.com Australia
Kestra Medical Technologies: Strong Financial Performance and Market Leadership Drive Buy Rating - TipRanks
Kestra raises FY26 revenue guidance to $91M while targeting 70%+ gross margins with ASSURE system expansion - MSN
Is Kestra Medical Technologies Ltd a good long term investmentSector Performance Drivers & High Return Trading Strategies - earlytimes.in
Kestra Medical Technologies Ltd (KMTS) Q2 2026 Earnings Call Highlights: Revenue Surge and ... By GuruFocus - Investing.com Canada
Earnings call transcript: Kestra Medical Technologies Q2 2025 shows strong revenue growth By Investing.com - Investing.com South Africa
Earnings call transcript: Kestra Medical Technologies Q2 2025 shows strong revenue growth - Investing.com Australia
Kestra Medical raises FY26 revenue view to $91M from $88M, consensus $88.02M - TipRanks
Kestra Medical (KMTS) Q2 2026 Earnings Transcript - The Globe and Mail
Kestra Medical Technologies plunges 11% as quarterly loss exceeds estimates - Investing.com
Kestra Medical Technologies Q2 2026 Earnings Call Transcript - MarketBeat
KESTRA MEDICAL TECHNOLOGIES, LTD. SEC 10-Q Report - TradingView — Track All Markets
Kestra Medical reports Q2 EPS (64c), consensus (57c) - TipRanks
Kestra Medical Fiscal Q2 Loss Narrows, Revenue Rises; Fiscal 2026 Revenue Outlook Lifted - marketscreener.com
Kestra Medical Technologies plunges 11% as quarterly loss exceeds estimates By Investing.com - Investing.com South Africa
Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results - TradingView — Track All Markets
(KMTS) Kestra Medical Technologies Now Expects Full Year 2026 Revenue $91M, vs. FactSet Est of $88.1M - marketscreener.com
KMTS: Q2 FY26 revenue up 53% and gross margin surpasses 50%, with FY26 guidance raised to $91M - TradingView — Track All Markets
Earnings Flash (KMTS) Kestra Medical Technologies, Ltd. Reports Q2 Revenue $22.6M, vs. FactSet Est of $20.7M - marketscreener.com
Kestra Medical Technologies, Ltd. Revises Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
Kestra Medical Technologies announces public offering of common shares - MSN
A&O Shearman advised on Kestra Medical Technologies upsized USD158.7 million follow-on equity offering - A&O Shearman
Earnings To Watch: Kestra Medical Technologies Ltd (KMTS) Reports Q2 2025 Result - GuruFocus
Archimedes Vascular Announces Close of Series A Financing led by Sherpa Healthcare Partners and Appoints Raymond W. Cohen as Chairman of its Board of Directors - Quantisnow
Kestra Medical Technologies, Ltd. $KMTS Shares Sold by Omega Fund Management LLC - MarketBeat
Brown Advisory Inc. Increases Position in Kestra Medical Technologies, Ltd. $KMTS - Defense World
Assessing Kestra Medical Technologies (KMTS) Valuation After Its Recent Share Price Pullback - Yahoo Finance
Finanzdaten der Kestra Medical Technologies Ltd-Aktie (KMTS)
Es liegen keine Finanzdaten für Kestra Medical Technologies Ltd (KMTS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.33%
0.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):